Literature DB >> 11704987

Thyrotropin receptor mutations in thyroid diseases.

P M Yen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11704987     DOI： 10.1023/a:1010076706666

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  59 in total

1.  A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family.

Authors:  D H Khoo; J Parma; C Rajasoorya; S C Ho; G Vassart
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

Review 2.  TSH receptor and disease.

Authors:  M Tonacchera; J Van Sande; J Parma; L Duprez; F Cetani; S Costagliola; J E Dumont; G Vassart
Journal:  Clin Endocrinol (Oxf)       Date:  1996-06       Impact factor: 3.478

Review 3.  The thyrotropin receptor in thyroid diseases.

Authors:  R Paschke; M Ludgate
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

Review 4.  The cAMP in thyroid: from the TSH receptor to mitogenesis and tumorigenesis.

Authors:  N Uyttersprot; A Allgeier; M Baptist; D Christophe; F Coppee; K Coulonval; S Deleu; F Depoortere; S Dremier; F Lamy; C Ledent; C Maenhaut; F Miot; V Panneels; J Parma; M Parmentier; I Pirson; V Pohl; P Roger; V Savonet; M Taton; M Tonacchera; J van Sande; F Wilkin; G Vassart
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1997

5.  Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas.

Authors:  M Derwahl; C Hamacher; D Russo; M Broecker; D Manole; H Schatz; P Kopp; S Filetti
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

6.  Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters.

Authors:  H P Holzapfel; D Führer; P Wonerow; G Weinland; W A Scherbaum; R Paschke
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

7.  Imparied cyclic-AMP response to thyrotrophin in congenital hypothyroidism with thyroglobulin deficiency.

Authors:  G A Medeiros-Neto; M Knobel; M D Bronstein; J Simonetti; F F Filho; E Mattar
Journal:  Acta Endocrinol (Copenh)       Date:  1979-09

8.  Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism.

Authors:  K O Schwab; M Gerlich; M Broecker; P Söhlemann; M Derwahl; M J Lohse
Journal:  J Pediatr       Date:  1997-12       Impact factor: 4.406

9.  Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice.

Authors:  F M Michiels; B Caillou; M Talbot; F Dessarps-Freichey; M T Maunoury; M Schlumberger; L Mercken; R Monier; J Feunteun
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism.

Authors:  C Ledent; J E Dumont; G Vassart; M Parmentier
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598
View more
  4 in total

1.  Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.

Authors:  K S Banu; P Govindarajulu; M M Aruldhas
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 2.  Naturally occurring C-terminal splice variants of nuclear receptors.

Authors:  Michiel van der Vaart; Marcel J M Schaaf
Journal:  Nucl Recept Signal       Date:  2009-06-19

Review 3.  Animal models to study thyroid hormone action in cerebellum.

Authors:  Noriyuki Koibuchi
Journal:  Cerebellum       Date:  2009-01-07       Impact factor: 3.847

4.  A newly identified insertion mutation in the thyroid hormone receptor-beta gene in a Korean family with generalized thyroid hormone resistance.

Authors:  Ji Hye Kim; Tae Sun Park; Hong Sun Baek; Gu Hwan Kim; Han Wook Yoo; Ji Hyun Park
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.